Loading…

Retroperitoneal liposarcoma excreting insulin‐like growth factor 2 that induced severe hypoglycemia

Insulin‐like growth factor 2 is overexpressed in various cancers, and is associated with a poor prognosis. Also, it is known that insulin‐like growth factor 2 is an etiology of non‐islet cell tumor hypoglycemia. In this report, we describe a case of unexpected hypoglycemia caused by a dedifferentiat...

Full description

Saved in:
Bibliographic Details
Published in:International journal of urology 2017-02, Vol.24 (2), p.162-165
Main Authors: Kato, Takuma, Sugimoto, Mikio, Yamashita, Motoki, Miyauchi, Yasuyuki, Hirama, Hiromi, Tsunemori, Hiroyuki, Ueda, Nobufumi, Imachi, Hitomi, Shibuya, Shinsuke, Kushida, Yoshio, Kakehi, Yoshiyuki
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Insulin‐like growth factor 2 is overexpressed in various cancers, and is associated with a poor prognosis. Also, it is known that insulin‐like growth factor 2 is an etiology of non‐islet cell tumor hypoglycemia. In this report, we describe a case of unexpected hypoglycemia caused by a dedifferentiated liposarcoma producing insulin‐like growth factor 2. A large mass in the retroperitoneum was detected in a 61‐year‐old man who complained of appetite loss. Despite having no history of diabetes mellitus, hypoglycemia suddenly occurred after admission, but oral glucose therapy was ineffective. After total parenteral nutrition, tumor resection was attempted, but failed as a result of rigid adhesion to the surrounding organs. The patient died of the disease 21 days after surgery. Pathological diagnosis at autopsy revealed dedifferentiated liposarcoma, and immunohistochemical staining showed that the tumor excreted insulin‐like growth factor 2. The possibility of an insulin‐like growth factor 2‐producing tumor should be taken into consideration when we encounter a patient with spontaneous hypoglycemia resistant to glucose substitution therapy.
ISSN:0919-8172
1442-2042
DOI:10.1111/iju.13276